Literature DB >> 15100307

Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells.

Daniele Saverino1, Fabio Ghiotto, Andrea Merlo, Silvia Bruno, Lorenzo Battini, Marzia Occhino, Massimo Maffei, Claudya Tenca, Stefano Pileri, Lucia Baldi, Marina Fabbi, Angela Bachi, Amleto De Santanna, Carlo E Grossi, Ermanno Ciccone.   

Abstract

Immune evasion mechanisms of human CMV are known; however, the immune control of infection remains poorly elucidated. We show that interaction between the viral protein UL18 on infected cells and the invariant receptor CD85j/LIR-1/ILT2 expressed on CTL is relevant for the control of infection. Resting and activated CD8(+) T cells lysed UL18 expressing cells, whereas cells infected with CMV defective for UL18 were not killed. Lysis was not dependent on CD8(+) T cell Ag specificity, MHC-unrestricted and specifically blocked by anti-CD85j and anti-UL18 mAb. Moreover, soluble recombinant UL18Fc immunoprecipitated CD85j from T cells. Activation is mediated by CD85j and its pathway is unrelated to CD3/TCR engagement. UL18 is detected in immunocompromised patients with productive infection and the mechanism used in vivo by human CMV to ensure survival of the immunocompetent host may be mediated by activation signals delivered by infected cells to T lymphocytes via UL18/CD85j interactions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100307     DOI: 10.4049/jimmunol.172.9.5629

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

Review 1.  Functional and genetic diversity of leukocyte immunoglobulin-like receptor and implication for disease associations.

Authors:  Kouyuki Hirayasu; Hisashi Arase
Journal:  J Hum Genet       Date:  2015-06-04       Impact factor: 3.172

2.  Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.

Authors:  Sandra Lopez-Vergès; Jeffrey M Milush; Brian S Schwartz; Marcelo J Pando; Jessica Jarjoura; Vanessa A York; Jeffrey P Houchins; Steve Miller; Sang-Mo Kang; Phillip J Norris; Douglas F Nixon; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

Review 3.  Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.

Authors:  Joana Loureiro; Hidde L Ploegh
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

4.  Crystal structure of the murine cytomegalovirus MHC-I homolog m144.

Authors:  Kannan Natarajan; Ashleigh Hicks; Janet Mans; Howard Robinson; Rongjin Guan; Roy A Mariuzza; David H Margulies
Journal:  J Mol Biol       Date:  2006-02-09       Impact factor: 5.469

5.  Effects on innate immunity of a therapeutic dendritic cell-based vaccine for HIV-1 infection.

Authors:  José Peña; Mario Frías; Laura Castro-Orgaz; Rafael González; Felipe García; Teresa Gallart; Jose María Gatell; Montserrat Plana
Journal:  Viral Immunol       Date:  2012-01-10       Impact factor: 2.257

Review 6.  Leukocyte immunoglobulin-like receptors in human diseases: an overview of their distribution, function, and potential application for immunotherapies.

Authors:  Jilu Zhang; Sunny Mai; Hui-Ming Chen; Kyeongah Kang; Xian Chang Li; Shu-Hsia Chen; Ping-Ying Pan
Journal:  J Leukoc Biol       Date:  2017-03-28       Impact factor: 4.962

7.  Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllers.

Authors:  Jinghe Huang; Patrick S Burke; Thai Duong Hong Cung; Florencia Pereyra; Ildiko Toth; Bruce D Walker; Luis Borges; Mathias Lichterfeld; Xu G Yu
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

8.  Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2.

Authors:  Mar Valés-Gómez; Mitsunori Shiroishi; Katsumi Maenaka; Hugh T Reyburn
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

9.  LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions.

Authors:  Kang Yu; Chelsea L Davidson; Agnieszka Wójtowicz; Luiz Lisboa; Ting Wang; Adriana M Airo; Jean Villard; Jeremie Buratto; Tatyana Sandalova; Adnane Achour; Atul Humar; Katia Boggian; Alexia Cusini; Christian van Delden; Adrian Egli; Oriol Manuel; Nicolas Mueller; Pierre-Yves Bochud; Deborah N Burshtyn
Journal:  J Clin Invest       Date:  2018-03-12       Impact factor: 14.808

10.  Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors.

Authors:  María Luisa Pita-Lopez; Inmaculada Gayoso; Olga DelaRosa; Javier G Casado; Corona Alonso; Elisa Muñoz-Gomariz; Raquel Tarazona; Rafael Solana
Journal:  Immun Ageing       Date:  2009-08-28       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.